Sullivan Jeremy A, Grummer Mary A, Yi Fu-Xian, Bird Ian M
Department of Obstetrics and Gynecology, Perinatal Research Laboratories, University of Wisconsin, Madison, 53715, USA.
Endocrinology. 2006 May;147(5):2442-57. doi: 10.1210/en.2005-0399. Epub 2006 Feb 2.
During pregnancy, vascular remodeling and vasoactive agents such as nitric oxide (NO) increase blood flow to the uteroplacental unit. Using our uterine artery endothelial cell (UAEC) culture model, based on cells from pregnant (P-UAEC) and nonpregnant (NP-UAEC) ewes, we investigate the relative physiological roles of Ca(2+) vs. kinase in the regulation of endothelial NO synthase (eNOS) activity. When Ca(2+) mobilization is fully inhibited using inhibitors of phospholipase C (PLC) (U73122) and the inositol triphosphate (IP3) receptor (IP3-R) (2-APB), significant residual eNOS activity remains in both P- and NP-UAEC. No change in ATP-stimulated ERK2, Akt, or eNOS phosphorylation is observed with U73122 (0.01-1 microM) or 2-APB (1-50 microM). The MAPK kinase (MEK) 1/2 inhibitor U0126 (10 microM) did not alter ATP-stimulated eNOS activity in P-UAEC, but potentiated the ATP response in NP-UAEC. Using two phosphatidylinositol 3-kinase (PI3-K) inhibitors, we observed no effect with LY294002 (10 microM) on eNOS activity in P- and NP-UAEC, but wortmannin (10 microM) inhibited both P- and NP-UAEC eNOS activation. Expression of constitutively active Akt (ca-Akt) in UAEC resulted in slight elevation of basal eNOS activity, but relative ATP-stimulated eNOS activation was not altered by ca-Akt. Wortmannin continued to inhibit eNOS activation by ATP in the presence of ca-Akt; LY294002 still had no inhibitory effect. Our data indicate both Ca(2+) and multiple kinases are involved in the regulation of eNOS activity in our model. We report that pregnancy adaptation of eNOS activation includes the reduced sensitivity to ERK-mediated attenuation of eNOS activity and enhanced stimulation of eNOS activity through a wortmannin-sensitive, LY294002-insensitive, Akt-independent mechanism.
在孕期,血管重塑以及一氧化氮(NO)等血管活性物质会增加子宫胎盘单位的血流量。利用我们基于怀孕(P-UAEC)和未怀孕(NP-UAEC)母羊细胞构建的子宫动脉内皮细胞(UAEC)培养模型,我们研究了Ca(2+)与激酶在内皮型一氧化氮合酶(eNOS)活性调节中的相对生理作用。当使用磷脂酶C(PLC)抑制剂(U73122)和肌醇三磷酸(IP3)受体(IP3-R)抑制剂(2-APB)完全抑制Ca(2+)动员时,P-UAEC和NP-UAEC中仍存在显著的残余eNOS活性。使用U73122(0.01 - 1 microM)或2-APB(1 - 50 microM)时,未观察到ATP刺激的ERK2、Akt或eNOS磷酸化发生变化。丝裂原活化蛋白激酶(MEK)1/2抑制剂U0126(10 microM)并未改变P-UAEC中ATP刺激的eNOS活性,但增强了NP-UAEC中的ATP反应。使用两种磷脂酰肌醇3-激酶(PI3-K)抑制剂,我们观察到LY294002(10 microM)对P-UAEC和NP-UAEC中的eNOS活性无影响,但渥曼青霉素(10 microM)抑制了P-UAEC和NP-UAEC中eNOS的激活。在UAEC中组成型活性Akt(ca-Akt)的表达导致基础eNOS活性略有升高,但ca-Akt并未改变相对ATP刺激的eNOS激活。在存在ca-Akt的情况下,渥曼青霉素继续抑制ATP对eNOS的激活;LY294002仍然没有抑制作用。我们的数据表明,在我们的模型中,[Ca(2+)]i和多种激酶都参与了eNOS活性的调节。我们报告称,eNOS激活的孕期适应性包括对ERK介导的eNOS活性衰减的敏感性降低,以及通过一种渥曼青霉素敏感、LY294002不敏感、Akt非依赖性机制增强对eNOS活性的刺激。